Avalyn Pharma Inc. Common Stock

NASDAQ:AVLN

Medical - Pharmaceuticals

Healthcare
$27.69 +1.77%

+$0.52 today

Market cap
$1.23B
Beta
0.00
52W Low $24.15High $32.23

Volume 0.40M

Average 0.51M

AVLN Change in Working Capital

Cash absorbed or released by changes in receivables, inventory, payables, and other operating balances.

No reported Change in Working Capital figures are available to summarize.

Change in Working Capital history

Currency unavailable · from the cash flow

No Change in Working Capital data reported for this period type.

Change in Working Capital vs competitors

How AVLN compares with its peers on the latest reported figures

AVLN Competitors
Change in Working Capital for AVLN and competitors
Company Period LTM YoY 3-year CAGR% of revenue
INSMInsmed IncorporatedLTM Jun 2026$112.89M USD+155.6%—9.9%
MNKDMannKind CorporationLTM Mar 2026$89.43M USD+79.1%+53.1%24.8%
VCREVicore Pharma Holding ABLTM Jun 2026SEK 39.64M SEK+63.6%—2980.4%
GYREGyre Therapeutics, Inc.LTM Mar 2026$2.69M USD-83.4%+25.9%2.3%
AVLNAvalyn Pharma Inc. Common Stock—— ———
Peer median (excluding AVLN) —+71.4%+39.5%17.4%

Competitors are the stored peer set for AVLN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Avalyn Pharma Inc. Common Stock

NASDAQ:AVLN

Intrinsic Alpha fair value

Locked

Current Price

$27.69

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.